The largest database of trusted experimental protocols

Mtesr media

Manufactured by STEMCELL
Sourced in Canada, United States

MTeSR is a serum-free, feeder-free, defined culture medium formulated for the maintenance of human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) in an undifferentiated state. The medium is a complete system that supports the self-renewal and pluripotency of stem cells without the need for a feeder layer or serum.

Automatically generated - may contain errors

56 protocols using mtesr media

1

Maintenance of Human mc-iPS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mc-iPS cells21 were obtained from System Biosciences (SC301A-1) and were maintained on Matrigel (BD Bioscience) coated plates in mTeSR media (Stem Cell Technologies) with 50 units/ml penicillin-streptomycin (Thermo Fisher Scientific) and with daily medium changes22 (link). For passaging, the cells were washed with PBS and treated with Accutase (Thermo Fisher Scientific) at 37 °C°C for 5 min. The cells were re-suspended in mTeSR media, centrifuged at 80 g for 5 min and cell pellets re-plated in mTeSR media supplemented with 10 μM ROCK Inhibitor Y-27632 (Cayman Chemical).
+ Open protocol
+ Expand
2

hiPSC-Derived Macrophage Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSC-derived macrophage differentiation protocol was adapted from Yanagimachi et al.69 (link) and modified from Mesci et al.38 (link) Briefly, iPSC cell lines were generated as previously described, by reprogramming fibroblast from a healthy donor.70 (link) The iPSC colonies were plated on Matrigel-coated (BD Biosciences) plates and maintained in mTESR media (Stem Cell Technologies). The protocol of myeloid cell lineage consisted of 4 sequential steps. In the first step, primitive streak cells were induced by BMP4 addition, which in step 2, were differentiated into hemangioblast-like hematopoietic precursors (VEGF (80 ng/mL, Peprotech), SCF (100 ng/mL, Gemini) and basic fibroblast growth factor (bFGF), (25 ng/mL, Life Technologies)). Then, in the third step, the hematopoietic precursors were pushed towards myeloid differentiation (FLT-3 ligand (50 ng/mL, HumanZyme), IL-3 (50 ng/mL, Gemini), SCF (50 ng/mL, Gemini), Thrombopoietin, TPO (5 ng/mL), M-CSF (50 ng/mL)) and finally into the monocytic lineage in step 4 [FLT3-ligand (50 ng/mL), M-CSF (50 ng/mL), GM-CSF (25 ng/mL)]. Cells produced in suspension in step 4 were recovered, sorted by using anti-CD14 magnetic microbeads (MACS, Miltenyi) and then integrated into 3D bioprinted models as described above.
+ Open protocol
+ Expand
3

Human iPSC Lines for ALS Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC lines were obtained from the Target ALS Repository, Harvard University, Jackson Laboratory, and the NINDS Human Cell and Data Repository (NHCDR). Human iPSC lines included non-isogenic control lines 11a [9 (link)], ND50003 (FA0000010) and KOLF2.1 J [75 (link)] and five fALS lines harboring mutations in C9orf72: 19f [45 (link)], NDS00268 (ND50074), NDS00269 (ND50075), NDS00270 (ND50076), and NDS00273 (ND50080). An isogenic pair of lines consisting of an unedited control TDP-43+/+ line and an edited TDP-43+/G298S iPSC line (harboring a single fALS mutation) was previously generated [77 (link)]. iPSCs were cultured as described previously [65 (link)]. Briefly, iPSCs were maintained on Matrigel-coated 6 well-plates (Corning, 354,277, and Falcon, 353,046) in mTeSR media (Stemcell Technologies, 85,850) for SMN differentiation or mTeSR Plus media (Stemcell Technologies, 100–0274) for NGN2 induction at 37 °C with 5% CO2.
+ Open protocol
+ Expand
4

Feeder-free H9 hESC-derived Induced Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9 hESCs were maintained under feeder-free conditions in mTeSR media (STEMCELL Technologies). Media was changed every day. When cell density reached 70%–80% confluence, colonies were dissociated using accutase (STEMCELL Technologies) and plated onto Matrigel (BD Biosciences)-coated plates at a 1:6 dilution. During passaging, the media was supplemented with 2 μM thiazovivin overnight. For hESC-iN formation, dissociated single cells were plated at a density of ∼2.5 × 105 cells per 35 mm2 well. Lentivirus infections (with an additional EGFP-expressing virus) and transgene induction were performed similarly to as described for the fibroblast-iN production, using N3 media. Puromycin selection continued from day 2–6 postinfection, with media changes every other day. On day 7, cells were dissociated into single cells using PBS-EDTA (0.5 mM) and seeded onto mouse glia. The next day, media was replaced with Neurobasal media (Neurobasal [Invitrogen], L-glut [Invitrogen], B27 [Invitrogen], penicillin/streptomycin [Invitrogen], doxycycline [2 μg/ml], BDNF [10 ng/ml] [PeproTech], GDNF [20 ng/ml] [PeproTech], and Ara-C). Media was half-exchanged every 3–4 days.
+ Open protocol
+ Expand
5

Spheroid Culture of Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUES-8 and H9 cells (both hESC lines) as well as 1016 (hiPSC line) were cultured as spheroids in 30 mL spinner flasks (ABLE Biott, Japan). Suspension cultures were established by seeding 15 million cells (5 × 105 cells mL−1) in mTeSR media (STEMCELL Technologies, Vancouver, Canada) with 10 µM Y27632 (STEMCELL Technologies, Vancouver, Canada). The spinner flasks were placed on a stir plate at the speed of 70 rpm inside the humidified incubator at 37 °C, and 5% CO2. Media was changed at 48 h to mTeSR without Y27632. Cells were passaged every 72 h by dispersing to single cells using Accutase and resuspended in fresh mTeSR with Y27632.
When assessing effects of shear stress, stem cells spheroids were kept in mTeSR media for 3 days. For additional 5 days, spheroids were maintained in the MCDB131-based media with additives described in detail in our previous work as S1 media37 (link). The latter media was used to minimize proliferation of spheroids.
+ Open protocol
+ Expand
6

Reprogramming Human Fibroblasts to iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reprogramming of human fibroblasts was carried out using two more genes (c-MYC and KLF4) in addition to four genes (OCT4, SOX2, NANOG and LIN28) described originally [36 (link)]. Briefly, fibroblast cells seeded at 0.2 X 106 cells/well of a 6-well plate in fibroblast medium (DMEM + 10% FBS) were transduced with six lentiviral vectors designed to deliver human OCT4, SOX2, c-MYC, KLF4, Nanog and Lin28 cDNA sequences [37 (link)]. On the next day, fresh fibroblast media was added to the cells 24 hours after transduction. At 48 hours after transduction the media was changed to half E8 medium and half fibroblast medium. When the cells reached about 60% confluence they were passaged to 10 cm Matrigel-coated plates (one well of a 6-well plate into one 10 cm dish) in E8 medium (StemCell Technologies) and media was replaced daily. Between day 15 and day 30 in culture, individual hiPS clones were manually picked using Leica stereomicroscope. Each hiPS clone was expanded and characterized by immunofluorescence for the expression of Oct4 and Tra-1-60. IPSCs were cultured on a Matrigel (BD-Biosceicnes) coated plate in IPSC medium (mTeSR media from Stemcell technologies, Vancouver, Canada) and media was changed daily until cells were ready for passage.
+ Open protocol
+ Expand
7

Fibroblast to Pluripotent Stem Cell Reprogramming

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sex chromosomal mosaicism in starting fibroblasts (partial 45,X recorded in Coriell Biorepository) was confirmed by interphase DNA FISH using sex centromere (DXZ1/DYZ3) probes (WiCell). Fibroblasts were reprogrammed to hiPSCs using the CytoTune iPSC 2.0 Sendai Reprogramming kit (Thermo Fisher Scientific) and maintained by weekly mechanical passaging, as described (26 (link)). Prior to BAP differentiation, hiPSCs were transitioned to mTeSR media (Stem Cell Technologies), grown on extracellular matrix (Geltrex, Thermo Fisher), and passaged weekly with ethylenediaminetetraacetic acid. Standard IF was performed for pluripotency markers and H3K27me3, as well as FISH and qRT-PCR for XIST (SI Appendix, SI Methods include details).
+ Open protocol
+ Expand
8

Generation of ABCA3 Mutant iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
All human iPSCs were maintained in feeder-free conditions, cultured on Matrigel-coated (Corning) plates in mTeSR media (StemCell Technologies), and passaged using Gentle Cell Dissociation Reagent (StemCell Technologies). Reprogramming of the BU3 human iPSC line was previously reported in Kurmann et al. (65 (link)), and editing of this line to target an ABCA3:GFP fusion cassette to the endogenous ABCA3 locus (BU3ABCA3:GFP) was previously reported in Sun et al. (39 (link)). For derivation of ABCA3 mutant patient-specific iPSC lines, dermal fibroblasts from each individual were received from Washington University School of Medicine. Genetic evaluation found no mutations in other genes associated with surfactant production, such as SFTPC or SFTPB genes. Reprogramming of dermal fibroblasts from individuals with homozygous E690K or homozygous W308R ABAC3 mutations was performed as detailed in the Supplemental Methods.
+ Open protocol
+ Expand
9

Directed Differentiation of Pluripotent Stem Cells to Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hESC line RUES2 (NIHhESC-09–0013, WiCell, RUESe002-A) and hiPSC line WTC #11 (Coriell Institute, GM25256), previously derived in the Conklin laboratory85 (link), were cultured on Matrigel growth factor-reduced basement membrane matrix (Corning) in mTeSR media (StemCell Technologies). A monolayer-based directed differentiation protocol was followed to generate hESC-CMs and hiPSC-CMs, as done previously26 (link). hiPSC-CM cardiolipin assay was done with a small molecule monolayer-based directed differentiation protocol, as done previously27 (link). Fifteen days after differentiation hPSC-CMs were enriched for the cardiomyocyte population using a lactate selection process86 (link). We generated cardiomyocyte populations ranging from 40–60% that were then enriched to 75–80% cardiomyocytes after 4 days of lactate enrichment.
+ Open protocol
+ Expand
10

Directed Differentiation of hiPSCs into Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All human pluripotent stem cell studies were carried out in accordance with consent from the University of Queensland’s Institutional Human Research Ethics approval (HREC#: 2015001434). hiPSCs were maintained in mTeSR media (Stem Cell Technologies, Cat.#05850). Unless otherwise specified, cardiomyocyte directed differentiation using a monolayer platform was performed with a modified protocol based on previous reports(Burridge et al., 2014 (link)). On day −1 of differentiation, hPSCs were dissociated using 0.5% EDTA, plated into vitronectin coated plates at a density of 1.8 × 105 cells/cm2, and cultured overnight in mTeSR media. Differentiation was induced on day 0 by first washing with PBS, then changing the culture media to RPMI (ThermoFisher, Cat.#11875119) containing 3μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500μg/mL BSA (Sigma Aldrich, Cat.#A9418), and 213μg/mL ascorbic acid (Sigma Aldrich, Cat.#A8960). After 3 days of culture, the media was replaced with RPMI containing 500μg/mL BSA, 213μg/mL ascorbic acid, and 5μM Xav-939 (Stem Cell Technologies, Cat.#72674). On day 5, the media was exchanged for RPMI containing 500μg/mL BSA, and 213μg/mL ascorbic acid without supplemental cytokines. From day 7 onwards, the cultures were fed every 2 days with RPMI plus 1x B27 supplement plus insulin (Life Technologies Australia, Cat.#17504001).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!